Date post: | 09-Apr-2017 |
Category: |
Documents |
Upload: | cameron-corbin |
View: | 28 times |
Download: | 0 times |
EbolaThe Deadly African Virus
http://www.youtube.com/watch?v=aE69K_lP2ug (2min)
Virus Classification
Group: Group V (-)ssRNA Order:Mononegavirales
Family:Filoviridae Genus:Ebolavirus
History
Outbreaks
Outbreaks Continued
Summary of Lethality
Possible Origin?
Transmission/Target Groups
Tissue/Organ Damage Methods Pro-Inflammatory Cytokines –
promotes systemic inflammation Coagulation (thrombogenesis) is the
process by which blood forms clots.
Incubation Period From 2-21 Days Early Symptoms Severe headache Weakness Muscle aches
Delayed Symptoms Severe vomiting Abdominal pain Diarrhea Pharyngitis (throat
inflammation) Conjunctivitis (Pink
Eye) External bleeding Extremely high body
temperature Prostration
Unfortunate Result
Diagnosis/Laboratory Testing ELISA- The enzyme-linked
immunosorbent assay (ELISA) is a test that uses antibodies and color change to identify a substance
The polymerase chain reaction (PCR) is a biochemical technology that generates thousands to millions of copies of a particular DNA sequence
THERE IS NO CURE FOR EBOLA
Safety Precautions
Future Outlook
Citations“Ebola Hemorrhagic Fever.” Special Pathogens Branch: Diseases.
Nov. 26, 2003. Center for Disease Control and Prevention. 3/19/04 <http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/ebola.htm>
Murphy, Frederick A. “Ebola Virus.” Encarta. CD-ROM. Microsoft, 2002
Russell, Brett. Ebola Information. 3/19/04 <http://www.brettrussell.com/personal/ebola.html>
Col. Weeks, Byron, M.D. “Ebola – A Serious Threat.” NewsMax.com. Oct. 17, 2001. 3/19/04 <http://www.newsmax.com/archives/articles/2001/10/12/82239.shtml>
Citations Continued http://www.cdc.gov/ncidod/dvrd/spb/mnpages/
dispages/ebotabl.htm http://www.who.int/mediacentre/factsheets/fs103/
en/ Hampton, Tracy. Vaccines Against Ebola and
Marburg Viruses Show Promise in Primates Studies. Maedical News and Perspectives. JAMA. Vol. 294 No. 2 July 2005.
Jones, Steven. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nature Medicine. Vol. 11 No. 7 July 2005.